Navigation Links
Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale d'Urologie
Date:9/5/2007

ding Canada and Mexico) and India.

In addition, Spectrum will receive 50 percent of any upfront and milestone payments, royalties and/or profits from sales of the product in Japan. Japanese rights for all potential oncology indications have recently been licensed to Nippon Kayaku, a key player in the Japanese oncology market.

Spectrum is developing ozarelix for benign prostatic hypertrophy (BPH), hormone-dependent prostate cancer and other indications.

About Benign Prostatic Hypertrophy

Benign prostatic hypertrophy is a non-cancerous enlargement of the prostate frequently occurring in men over the age of 50. According to the National Institutes of Health, BPH affects more than 50% of men over the age of 60 and as many as 90% of men over the age of 70 and it is estimated that there are currently more than 28 million men suffering from BPH in the United States.

The IPSS (also known as AUA symptom index) is a standardized scoring system that evaluates the seven principal symptoms of BPH. The enlargement can result in the gradual squeezing of the urethra, resulting in increased frequency or difficulty in urinating. Treatment options for BPH include surgery and medications to reduce the amount of tissue and increase the flow of urine. Current treatment options have limited efficacy, leading to inadequate compliance. Medications currently available belong to two classes: alpha blockers (such as FLOMAX(R)[1], CARDURA(R)[2] and HYTRIN(R)[3]) which relax the muscles in the neck of the bladder and in the prostate, but have no direct effect on the prostate growth itself, and alpha reductase inhibitors (such as PROSCAR(R)[4] and AVODART(R)[5]), which can result in some reduction of the prostate size but have a very slow onset of action, and may be associated with impotence and decreased libido.

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals acquires, develops and commercializes a diversified portfolio of oncology drug candidate
'/>"/>

SOURCE Spectrum Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AEterna Zentaris Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting
2. Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014  The objective of this market insight ... and research facilities across North America ... study carries out an assessment of the current and ... and law enforcement forensics labs. It also provides a ... PPE segments, and safety regulations specific to labs and ...
(Date:9/23/2014)... PARIS , September 23, 2014 /PRNewswire/ ... tels que l,automobile, la santé, le ferroviaire ... en plus connectées, donneront progressivement accès à ... issues des nombreux capteurs installés au cœur ... estime à plusieurs dizaines de milliards le ...
(Date:9/23/2014)... Sept. 23, 2014 Research and ... "Physician Office Laboratory Markets, 3rd Edition" ... report, Physician Office Laboratory Markets is Kalorama,s complete ... industry. Physician office laboratories are diverse in their ... reimbursable, in-office pregnancy and glucose tests. Some specialty ...
Breaking Medicine Technology:Personal Protective Equipment (PPE) Outlook for the North American and Western European Labs and Research Facilities 2Personal Protective Equipment (PPE) Outlook for the North American and Western European Labs and Research Facilities 3Altran transforme le big data du monde industriel en nouveau business 2Physician Office Laboratory Markets, 3rd Edition 2Physician Office Laboratory Markets, 3rd Edition 3
(Date:9/23/2014)... News) -- The number of ,rogue, wholesale distributors ... so doctors need to be vigilant when purchasing ... Tuesday. In a statement, the agency said ... launched a program to educate doctors and other ... purchasing procedures. The program aims to protect patients ...
(Date:9/23/2014)... benefits of preventing a reduction in the rates ... today by the American College of Physicians (ACP). ... Medicaid Primary Care Pay Parity Program: Unless Congress ... Care Will Expire," explains why it is critical ... pediatricians (and their related subspecialists), family physicians, and ...
(Date:9/23/2014)... 23, 2014 Trevera provides multiple ... Included are Oracle Managed Services , Oracle ... all versions of Oracle E-Business Databases and ... , Trevera has announced a significant enhancement to ... help with their software technology management, project management, ...
(Date:9/23/2014)... Boston, MA (PRWEB) September 23, 2014 ... announced that $50,000 investments each were made to ... the top two health ventures with business solutions to ... , SOURCE is a first-of-its-kind collaboration between The ... Investors' Circle that connects entrepreneurs with the investment ...
(Date:9/23/2014)... HealthDay Reporter MONDAY, Sept. ... demanding action on climate change, a new study warns ... United States may soon exacerbate many existing health risks. ... are expected to increase as the number of extremely ... director of the Global Health Institute at the University ...
Breaking Medicine News(10 mins):Health News:Unless Congress acts, patients may soon lose access to primary care 2Health News:Unless Congress acts, patients may soon lose access to primary care 3Health News:Trevera, Inc adds Management Support to Services 2Health News:Trevera, Inc adds Management Support to Services 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 2Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 3Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 4Health News:$100,000 Awarded to Rimidi Diabetes and TruClinic for Health Business Solutions that Benefit Patients and Providers 5Health News:Health Woes to Worsen Due to Climate Change, Study Warns 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 3
... 352,082 Australians who filled a prescription for asthma preventer medications ... June 2005, went on to use them regularly. , Most ... the next two years while 22% did so sporadically. , ... Australia and New Zealand (TSANZ) Conference which starts this Sunday ...
... IRIDEX,Corporation (Nasdaq: IRIX ) today announced that ... financial results after the market closes on,Thursday, April 10, ... a conference call with the investment community at 5:00 ... the results of the quarter and,other business developments., ...
... a Six Pack While Giving Back Through Fitness Fundraiser for St. ... Jude Children,s Research Hospital(R), ... will "feel the burn" as they crunch their abs for one,hour ... More than 200 local Lady of America, Ladies Workout,Express and Workout ...
... Sawyer Promoted; ... Bill McKee,s Role Expanded, MONTVALE, ... today announced the restructuring of its,senior management team to better ... increase efficiencies,across the global organization. Barr,s Chairman and Chief Executive,Officer, ...
... to Date, WASHINGTON, March 28 U.S.News ... 2009 edition of America,s Best,Graduate Schools, available at ... 2008. Examining more graduate programs than ever before,this ... the most,comprehensive guide to graduate schools across the ...
... March 28 Long-chain (seafood) omega-3,polyunsaturated fatty acids ... and eye health, according to recent research summarized ... Newsletter electronic publications.,Groundbreaking studies also show that omega-3s ... eye syndrome., The effect of fish oil ...
Cached Medicine News:Health News:4,000 Women Attempt New World Record at 2008 Lady of America/Ladies Workout Express Ab Crunch Challenge 2Health News:Barr Announces Reorganization of Senior Management, Business Functions 2Health News:Barr Announces Reorganization of Senior Management, Business Functions 3Health News:Barr Announces Reorganization of Senior Management, Business Functions 4Health News:Barr Announces Reorganization of Senior Management, Business Functions 5Health News:Barr Announces Reorganization of Senior Management, Business Functions 6Health News:Barr Announces Reorganization of Senior Management, Business Functions 7Health News:U.S.News & World Report Announces the 2009 Publication of America's Best Graduate Schools 2Health News:U.S.News & World Report Announces the 2009 Publication of America's Best Graduate Schools 3Health News:Omega-3 Fatty Acids Protect the Spinal Cord, Heart, Brain and Eyes 2
Indicated for procedures of the wrist, ankle, elbow, and other small joints, the,UltrAblator is effective for ablation of soft tissue and coagulation of bleeders,encountered during surgery....
... This implant is designed to replace the ... on the distal pole which fits under a ... bone, and a suture hole on the proximal ... anatomical position during the early postoperative period until ...
... has the same anatomical configuration as the ... to provide for stability. The implant has ... use in suture fixation through the scaphoid ... while a capsuloligamentous system forms around the ...
... for four corner fusion of the capitate, ... hand. The plate is intended for use ... of function due to SLAC and SNAC ... rheumatoid arthritis. When combined with the specially ...
Medicine Products: